AB Science reports phase 3 study results of masitinib in combination with Gemzar%C2%AE for treatment of pancreatic cancer.

ABCDEFGHIJKLMNOPQRSTUVWXYZ




To view the detailed information, you need to SUBSCRIBE with us.

 screenshot